Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer

THURSDAY, Sept. 19, 2024-- For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab yields a significant improvement in overall survival compared with neoadjuvant...